The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy.
Clin Radiol
; 75(1): 79.e9-79.e18, 2020 01.
Article
in En
| MEDLINE
| ID: mdl-31662200
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Positron-Emission Tomography
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Clin Radiol
Year:
2020
Document type:
Article
Country of publication:
United kingdom